HCV Infection on Lymphoid Neoplasm
Received Date: Apr 15, 2018 / Accepted Date: Apr 19, 2018 / Published Date: Apr 23, 2018
Abstract
Since there is a suggested a link between HCV and liver cancer, attempts are currently being made to discover new drugs that can advance the treatment of hepatitis C and prevent it from progressing to liver cancer. On the other hand, in the treatment of lymphoma, it has been pointed out that HCV is associated with HCV reactivation and lymphoproliferative diseases such as lymphoma. In this review, we will summarize the relationship between lymphoproliferative diseases and hepatitis due to reactivation of HCV during treatment with rituximab.
Keywords: Rituximab; Hepatitis C virus (HCV); Lamivudine; Non- Hodgkin’s lymphoma (NHL); Direct-acting anti-viral agents (DAA)
Citation: Tsutsumi Y, Yamamoto Y, Ito S, Sekine T, Matsuoka S, et al. (2018) HCV Infection on Lymphoid Neoplasm. J Infect Dis Ther 6: 360. Doi: 10.4172/2332-0877.1000360
Copyright: © 2018 Tsutsumi Y, et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium.
Share This Article
Recommended Journals
Open Access Journals
Article Tools
Article Usage
- Total views: 3781
- [From(publication date): 0-2018 - Nov 21, 2024]
- Breakdown by view type
- HTML page views: 3137
- PDF downloads: 644
